Skip to content
10-Q

Quarterly Report

Evolutionary Genomics, Inc.

0001553350-21-000955

← back to feed
Filed
Nov 1, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Sep 30, 2021 5.88M sh
Long Term Debt Q3 2021 · Sep 30, 2021 $3.74M
Long Term Debt Q3 2021 · Dec 31, 2020 $2.25M
Cash And Equivalents Q3 2021 · Sep 30, 2021 $605.51K
Cash And Equivalents Q3 2021 · Dec 31, 2020 $215.84K
Cash And Equivalents Q3 2021 · Sep 30, 2020 $320.64K
Cash And Equivalents Q3 2021 · Dec 31, 2019 $45.44K
Current Liabilities Q3 2021 · Sep 30, 2021 $39.66K
Current Liabilities Q3 2021 · Dec 31, 2020 $3.16K
Total Liabilities Q3 2021 · Sep 30, 2021 $3.78M
Total Liabilities Q3 2021 · Dec 31, 2020 $2.25M
Current Assets Q3 2021 · Sep 30, 2021 $629.8K
Current Assets Q3 2021 · Dec 31, 2020 $277.59K
Total Assets Q3 2021 · Sep 30, 2021 $3.57M
Total Assets Q3 2021 · Dec 31, 2020 $3.99M
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$749.07K
Stockholders Equity Q3 2021 · Sep 30, 2020 −$169.67K
Stockholders Equity Q3 2021 · Jun 30, 2020 −$760.48K
Stockholders Equity Q3 2021 · Mar 31, 2020 −$520.61K
Stockholders Equity Q3 2021 · Dec 31, 2019 −$333.73K
Sga Expense Q3 2021 · Sep 30, 2020 $118.95K
Sga Expense Q3 2021 · Sep 30, 2020 $225.45K
Rd Expense Q3 2021 · Sep 30, 2020 $138.13K
Rd Expense Q3 2021 · Sep 30, 2020 $398.88K
Net Income Q3 2021 · Sep 30, 2020 $535.89K
Net Income Q3 2021 · Sep 30, 2020 −$729
Operating Income Q3 2021 · Sep 30, 2020 −$474.51K
Operating Income Q3 2021 · Sep 30, 2020 −$1.01M
Revenue Q3 2021 · Sep 30, 2020 $12.5K